European Head and Neck Course International Symposium on HPV Infection in Head and Neck Cancer

Speakers

Ruud Brakenhoff

Andreas Dietz

Since April 2004, Prof. Dr. Andreas Dietz is Chair of the ENT University Clinic Leipzig. He is full-trained ENT and head and neck surgeon and has special qualification in plastic surgery and Oncology. His scientific work is reflected in numerous studies and translational projects on head and neck cancer. He is internationally known as an expert in this field. He was President of the German Society for ENT - Head and Neck Surgery (DGHNO-KHT) from 2019 to 2020 and is speaker of the interdisciplinary group of Head and Neck Cancer of the German Cancer Society (IAG-KHT). He holds visible positions on numerous international committees like membership of the Board of Directors of the European Head and Neck Society. He is speaker of the board of the Innovation Center for Computer-Assisted Surgery (ICCAS) Leipzig. He is a member of the Board of Directors of the Global Online Fellowship Initiative at Sloan Kettering Memorial Cancer Center in New York and Chair of the Surgery Subcommittee of the EORTC Head and Neck Group. He is honorary member of the Royal Belgian, the Austrian and Czech ENT Society and the Indian Head and Neck Foundation. Andreas Dietz is author/co-author of more than 500 pub-med listed publications. He coordinates the German S3-Guideline for oropharyngeal and hypopharyngeal cancer. Andreas Dietz was honored with the DGHNO-KHC Medal of Merit, the Order of Merit of the Free State of Saxony in 2022 and with the EHNS Award in 2023.

Mario Fernandez Fernandez

Robert Ferris

Robert L. Ferris, MD, PhD is Hillman Professor of Oncology and Director at UPMC Hillman Cancer Center, Director, UPMC Hillman Cancer Center, and Hillman Professor of Oncology, and UPMC Senior Vice President for Oncology Programs, and Associate Senior Vice Chancellor for Cancer Research, University Pittsburgh School of Medicine.

As a head and neck surgical oncologist and translational tumor immunologist, his lab performs neoadjuvant “window” trials developing novel immune-oncology agents, combinations and biomarkers. His group is uniquely positioned to investigate mechanisms of anti-tumor immunity in the tumor microenvironment (TME), as well as tumor cell escape. Dr. Ferris's NIH-funded laboratory is focused on reversal of immune escape and immunotherapy using monoclonal antibodies and vaccines, leading to the first randomized phase II-III trials of head and cancer immunotherapy in the world. He was founding director of the Hillman Tumor Microenvironment Center. He is a Principal Investigator of the University of Pittsburgh Specialized Program of Research Excellence (SPORE) grant for translational head and neck research and a R01 grant focused on T cell receptor dynamics and immune phenotypes regulating response to immunotherapy.

Dr. Ferris has an h-index of 105 and his >420 peer-reviewed scientific and clinical publications have garners >43,000 citations. He is lead investigator of several practice-changing, prospective randomized trials, including Checkmate-141 published in NEJM which led to the FDA approval of Nivolumab for head and neck cancer, ECOG 3311 (published in JCO in 2021), testing radiation dose-deintensification after transoral robotic surgery (TORS) for HPV+ oropharynx cancer, which is being incorporated into the latest NCCN guidelines. He currently leads ECOG-ACRIN 3132, using p53 mutational testing in HPV-negative cancer, to predict response to radiation versus chemoradiation.

Dr. Ferris currently serves on the Editorial Boards of JNCI, JCO, Clinical Cancer Research, and Cancer Immunology Research. He is Editor in Chief of Oral Oncology. He recently completed a 6-year term co- chairing the NCI Steering Committee for Head and Neck Cancer, served as a standing member of NCI Committee A reviewing Cancer Centers, and is currently President-Elect of the American Head and Neck Society. He has co-founded two early phase immuno-oncology companies, in therapeutics discovery and development and in cellular therapeutic strategies for solid and liquid tumors, and serves on multiple scientific advisory boards for various biotech companies.

Jeppe Friborg

Wojciech Golusiński

Paweł Golusiński

Chris Holsinger

Sefik Hosal

Joanna Kaźmierska

Luiz Paulo Kowalski

Stephan Lang

Rene Leemans

Professor C. René Leemans, MD, PhD is chair of the Department of Otolaryngology Head and Neck Surgery at the Amsterdam University Medical Centres, VUmc, Amsterdam. He is Director of the Advanced Fellowship Program in Head and Neck Surgery and Oncology at the VU University Medical Centre Amsterdam. His special interests include head and neck oncology, reconstructive and microvascular surgery, and basic research.

René Leemans has made a sustained and internationally recognised contribution to cancer care and research in the field of head and neck oncology over the past decades. His scientific standing has been recognised by election as President of the Netherlands Society of Otolaryngology-Head and Neck Surgery, and the Dutch and European Head and Neck Societies. He also serves on the Leadership of the American Head and Neck Society (AHNS). He (co-)authored more than 500 papers and book chapters on head and neck oncology and is regularly invited to speak at international conferences and tutor at courses. He was a travelling faculty member of 2010 Global CME program “Current Concepts in Head and Neck Surgery and Oncology” of the IFHNOS. In 2022 he was awarded the Eugene N. Myers, MD International Lecture on Head and Neck Cancer at the American Academy of Otolaryngology-Head and Neck Surgery Meeting in Philadelphia. He leads the impactful Make Sense Awareness Campaign.

Hisham Mehanna

Paolo Bossi

Piotr Radomyski

Christian Simon

Giovanni Succo

Otorhinolaryngologist and Surgical Oncologist

Full Professor Otolaryngology/Head and Neck Surgery – Dept. Oncology – University of Turin

Chair Otolaryngology/Head and Neck Unit - San Giovanni Bosco Hospital – Turin

President of European Head and Neck Society

President of Italian Head and Neck Society

Author of 127 peer reviewed papers and many book chapters mainly focused on laryngeal oncology, partial laryngectomies and, the last ones, on mini-invasive 3D Robotic like surgery.

Gunnar Wichmann

Office of the Organizer

Kinga Lunitz – Coordinator
15 Garbary St., 61-866 Poznan
Phone: +48 61 88 50 929
e-mail: kinga.lunitz@wco.pl

Venue

Congress and Education Center
Medical University of Karol Marcinkowski in Poznań
St. Przybyszewskiego 37a
60-356 Poznań/ POLAND